Inhaled bronchodilators for chronic bronchitis and emphysema - Document - Gale Academic OneFile
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial - The Lancet
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chro | JEP
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
SABA (short acting beta agonist) inhalers Aerosol InhalersGeneric Component No of doses Cost/ device Dosing directions Ventolin evohalerSalbutamol 100mcg/dose200£ ppt download
Natalies Casebook | Tag
Practical considerations when prescribing a long-acting muscarinic ant | COPD
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
Efficacy and Cardiovascular Safety of LAMA in Patients with COPD: A Systematic Review and Meta-Analysis - Chuchu Zhang, Meng Zhang, Yalei Wang, Huaiyu Xiong, Qiangru Huang, Tiankui Shuai, Jian Liu, 2021
Introduction - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD | European Respiratory Society
New developments in inhaled therapy | Practice Nursing
Preclinical Evaluation of Long-Acting Muscarinic Antagonists: Comparison of Tiotropium and Investigational Drugs | Journal of Pharmacology and Experimental Therapeutics
Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town | Allergo Journal International
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
Comparative Effectiveness and Safety of Different Types of Inhaled Long- Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
An additional effect of short-acting muscarinic antagonists plus... | Download Scientific Diagram